Form 4: Modular Medical Director Acquires Shares

Sentiment:

Statement of Changes in Beneficial Ownership


Steven G. Felsher, a Director at Modular Medical, Inc., reported the acquisition of 25 shares of common stock on March 31, 2026, as part of the company's Outside Director Compensation Plan.

Summary

  • Steven G. Felsher, a Director of Modular Medical, Inc., acquired 25 shares of common stock on March 31, 2026.
  • These shares were issued under the company's Outside Director Compensation Plan.
  • Following this transaction, Mr. Felsher beneficially owns 8,473 shares of common stock.
  • The reported share amount reflects a 1-for-30 reverse stock split that became effective on March 31, 2026.
  • An option to purchase common stock was also granted to Mr. Felsher on March 31, 2026, with an exercise price of $4.55, fully vested and exercisable on the grant date, expiring on March 31, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it reports routine director compensation and ownership adjustments, including a reverse stock split, which has mixed implications.

Positives

  • Director acquisition of shares indicates confidence in the company.
  • Shares were issued as part of a compensation plan, aligning director interests with the company's performance.
  • The option grant provides potential future upside for the director.

Negatives

  • The filing details a reverse stock split, which can sometimes be perceived negatively by the market as it may indicate a company's struggle to maintain a higher stock price.

Risks

  • The reverse stock split itself could be a risk if it does not lead to improved market perception or trading liquidity.
  • The value of the director's holdings and options is subject to the future performance of Modular Medical, Inc.'s stock.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The details pertain to past transactions and ownership.

Management Comments

  • The shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
  • The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

Industry Context

StockSavvy.ai notes that director stock acquisitions, especially when part of a compensation plan, are common in the biotech and medical device sectors as companies seek to attract and retain experienced leadership. The reverse stock split is a structural adjustment that many companies undertake to meet exchange listing requirements or improve stock appeal.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation PlanIssuance of common stock and stock options to a director under the company's Outside Director Compensation Plan.03/31/2026Reinforces alignment between director and shareholder interests; standard corporate governance practice.
Stock SplitImplementation of a 1-for-30 reverse stock split.03/31/2026Aims to increase the per-share market price of common stock, potentially improving marketability and meeting exchange listing requirements. May signal underlying stock price challenges.

Related Party Transactions

  • The acquisition of 25 shares of common stock and the grant of stock options to Director Steven G. Felsher are part of the company's standard Outside Director Compensation Plan, representing a related party transaction.

Stakeholder Impact

  • Shareholders: The reverse stock split may affect the perceived value and liquidity of their holdings. Director's increased ownership (post-split) could signal confidence, but the overall impact depends on future company performance.
  • Employees: May be indirectly affected by the stock split and the company's efforts to maintain exchange listings, which can impact morale and equity-based compensation.
  • Creditors: No direct impact from this filing.

Next Steps

  • Continued monitoring of Steven G. Felsher's beneficial ownership.
  • Observation of the impact of the reverse stock split on Modular Medical, Inc.'s stock performance and market perception.

Key Dates

DateDescription
03/31/2026Earliest transaction date reported; date of share acquisition and option grant; date of reverse stock split effective.
03/31/2036Expiration date of the granted stock option.
04/08/2026Date the Form 4 was signed by the attorney-in-fact.

Keywords

Modular Medical, MODD, Form 4, SEC Filing, Director Compensation, Stock Acquisition, Reverse Stock Split, Beneficial Ownership, Stock Options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.